UA92704U - Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus - Google Patents

Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus

Info

Publication number
UA92704U
UA92704U UAU201403913U UAU201403913U UA92704U UA 92704 U UA92704 U UA 92704U UA U201403913 U UAU201403913 U UA U201403913U UA U201403913 U UAU201403913 U UA U201403913U UA 92704 U UA92704 U UA 92704U
Authority
UA
Ukraine
Prior art keywords
patients
endothelial dysfunction
diagnostics
type
diabetes mellitus
Prior art date
Application number
UAU201403913U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Анна Сергеевна Шалимова
Марина Николаевна Кочуева
Анна Владимировна Линская
Игорь Геннадиевич Крайз
Татьяна Викторовна Шевела
Ольга Алексеевна Качанова
Original Assignee
Харьковская Медицинская Академия Последипломного Обучения
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковская Медицинская Академия Последипломного Обучения filed Critical Харьковская Медицинская Академия Последипломного Обучения
Priority to UAU201403913U priority Critical patent/UA92704U/en
Publication of UA92704U publication Critical patent/UA92704U/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus includes investigation of blood characteristics. Concentrations of pro-inflammatory cytokines TNF-α and IL-6 are determined In blood serum of patients by immunoenzyme method, and if the value of TNF-α is 182.4±7.4 pg/ml and higher and if IL-6 is 162.5±7.1 and higher the presence of endothelial dysfunction is diagnosed.
UAU201403913U 2014-04-14 2014-04-14 Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus UA92704U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201403913U UA92704U (en) 2014-04-14 2014-04-14 Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201403913U UA92704U (en) 2014-04-14 2014-04-14 Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus

Publications (1)

Publication Number Publication Date
UA92704U true UA92704U (en) 2014-08-26

Family

ID=52682099

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201403913U UA92704U (en) 2014-04-14 2014-04-14 Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus

Country Status (1)

Country Link
UA (1) UA92704U (en)

Similar Documents

Publication Publication Date Title
CO2020004831A2 (en) Dosage and administration of anti-c5 antibodies for the treatment of patients with membranoproliferative glomerulonephritis
RU2016147122A (en) APPLICATION OF SERELAXIN TO REDUCE GDF-15
WO2014169011A3 (en) Methods for treating immune diseases
UA92704U (en) Method for diagnostics of endothelial dysfunction in patients with hypertonic disease and type 2 diabetes mellitus
RU2014113841A (en) METHOD FOR EARLY DIAGNOSTICS OF ENDOGENOUS INTOXICATION
EA201401101A1 (en) METHOD OF LABORATORY DIAGNOSTICS OF PNEUMONIA
UA92604U (en) Method for diagnostics of severity of cardiac insufficiency with remained ejection fraction in patients affected by cardiac infarction at background of arterial hypertension
UA94058U (en) Method for diagnosing fracture healing
WO2015158608A3 (en) Diagnosis of chronic kidney disease by quantitative analysis of post-translational modifications of plasma proteins
UA92113U (en) Method for prediction of development of diabetes insular of 2 type in patients with hypertonic disease by activity of apeline
UA87683U (en) Method for diagnostics of left ventricle diastolic dysfunction in patients with hypertonic disease
UA106925U (en) A method for diagnosing of fibrosis appearance with pyelonephritis on the background of vesico-urinoexcretory reflux in infants
RU2015152392A (en) METHOD FOR SCREENING ONCOLOGICAL DISEASES ON ULTRASONIC RESEARCH OF BLOOD
UA94059U (en) Method for diagnosing fracture healing
UA106340C2 (en) Method for diagnosing state of patient with osteoarthrosis
RU2014121297A (en) METHOD FOR DIAGNOSTIC OF CHRONIC HEART FAILURE
WO2015190912A8 (en) Biomarker for severe dengue
XIN et al. Synergistic effect of family hypertension history and hyperuricemia on incidence of hypertension
UA94741U (en) METHOD OF DIAGNOSIS OF ANTYPHOSPHOLIPID SYNDROME
UA82237U (en) Method for early diagnostics of development of concomitant gastro-esophagiial reflux disease in patients with chronic obstructive lung disease
UA98300U (en) A method of diagnosing celiac disease in persons with selective immunoglobulin a deficiency
UA106267U (en) METHOD OF DIAGNOSing the PHASE of infectious-septic process in patients with infective endocarditis
UA94478U (en) A method for diagnosing the risk of atherosclerosis development in patients with antiphospholipid syndrome
吴茜 et al. Clinical aspects of MuSK-positive MG patients in China
Kim et al. D43 COPD: FACTORS ASSOCIATED WITH THE IMPLEMENTATION OF GOLD AND OTHER ORGANIZATIONS'RECOMMENDATIONS: The COPD Assessment Test (cat) Scores In Frequent Exacerbators Of COPD